Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Related Citations for PubMed (Select 23350771)

1.

Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Petsche Connell J, Camci-Unal G, Khademhosseini A, Jacot JG.

Tissue Eng Part B Rev. 2013 Aug;19(4):368-79. doi: 10.1089/ten.TEB.2012.0561. Epub 2013 Mar 14. Review.

2.

Evaluation of endothelial cells differentiated from amniotic fluid-derived stem cells.

Benavides OM, Petsche JJ, Moise KJ Jr, Johnson A, Jacot JG.

Tissue Eng Part A. 2012 Jun;18(11-12):1123-31. doi: 10.1089/ten.TEA.2011.0392. Epub 2012 Mar 9.

3.

Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.

Weber B, Zeisberger SM, Hoerstrup SP.

Placenta. 2011 Oct;32 Suppl 4:S316-9. doi: 10.1016/j.placenta.2011.04.001. Epub 2011 May 14. Review.

PMID:
21575988
4.

Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine.

Bajek A, Olkowska J, Gurtowska N, Kloskowski T, Walentowicz-Sadlecka M, Sadlecki P, Grabiec M, Drewa T.

Expert Opin Biol Ther. 2014 Jun;14(6):831-9. doi: 10.1517/14712598.2014.898749. Epub 2014 Mar 22. Review.

PMID:
24655038
5.

Endothelial differentiation of amniotic fluid-derived stem cells: synergism of biochemical and shear force stimuli.

Zhang P, Baxter J, Vinod K, Tulenko TN, Di Muzio PJ.

Stem Cells Dev. 2009 Nov;18(9):1299-308. doi: 10.1089/scd.2008.0331.

6.

Amniotic fluid-derived stem cells in regenerative medicine research.

Joo S, Ko IK, Atala A, Yoo JJ, Lee SJ.

Arch Pharm Res. 2012 Feb;35(2):271-80. doi: 10.1007/s12272-012-0207-7. Epub 2012 Feb 28. Review.

PMID:
22370781
7.

[Research development of amniotic fluid-derived stem cells in regenerative medicine].

Li C, Li W, Liu H, Wang J.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013 Oct;27(10):1262-6. Review. Chinese.

PMID:
24397143
8.

Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies.

Yeh YC, Wei HJ, Lee WY, Yu CL, Chang Y, Hsu LW, Chung MF, Tsai MS, Hwang SM, Sung HW.

Tissue Eng Part A. 2010 Jun;16(6):1925-36. doi: 10.1089/ten.TEA.2009.0728.

PMID:
20067384
9.

Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges.

Finosh GT, Jayabalan M.

Biomatter. 2012 Jan-Mar;2(1):1-14. doi: 10.4161/biom.19429. Review.

10.

Induced pluripotent stem cells for cardiac repair.

Zwi-Dantsis L, Gepstein L.

Cell Mol Life Sci. 2012 Oct;69(19):3285-99. doi: 10.1007/s00018-012-1078-2. Epub 2012 Jul 20. Review.

PMID:
22960788
11.

Formation of functional gap junctions in amniotic fluid-derived stem cells induced by transmembrane co-culture with neonatal rat cardiomyocytes.

Connell JP, Augustini E, Moise KJ Jr, Johnson A, Jacot JG.

J Cell Mol Med. 2013 Jun;17(6):774-81. doi: 10.1111/jcmm.12056. Epub 2013 May 2.

12.

The effect of differentiation stage of amniotic fluid stem cells on bone regeneration.

Rodrigues MT, Lee BK, Lee SJ, Gomes ME, Reis RL, Atala A, Yoo JJ.

Biomaterials. 2012 Sep;33(26):6069-78. doi: 10.1016/j.biomaterials.2012.05.016. Epub 2012 Jun 5.

PMID:
22672834
13.

Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.

Schmidt D, Achermann J, Odermatt B, Genoni M, Zund G, Hoerstrup SP.

J Heart Valve Dis. 2008 Jul;17(4):446-55; discussion 455.

PMID:
18751475
14.

Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.

Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, Zund G, Hoerstrup SP.

Circulation. 2007 Sep 11;116(11 Suppl):I64-70.

15.

Molecular and phenotypical characterization of human amniotic fluid cells and their differentiation potential.

Montemurro T, Bossolasco P, Cova L, Zangrossi S, Calzarossa C, Buiatiotis S, Soligo D, Silani V, Lambertenghi Deliliers G, Rebulla P, Lazzari L.

Biomed Mater Eng. 2008;18(4-5):183-5. No abstract available.

PMID:
19065019
16.

Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.

Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF.

Chin Med J (Engl). 2007 Apr 20;120(8):696-702.

PMID:
17517187
17.

In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells.

Bollini S, Pozzobon M, Nobles M, Riegler J, Dong X, Piccoli M, Chiavegato A, Price AN, Ghionzoli M, Cheung KK, Cabrelle A, O'Mahoney PR, Cozzi E, Sartore S, Tinker A, Lythgoe MF, De Coppi P.

Stem Cell Rev. 2011 Jun;7(2):364-80. doi: 10.1007/s12015-010-9200-z.

PMID:
21120638
18.

Heart repair and stem cells.

van Laake LW, Hassink R, Doevendans PA, Mummery C.

J Physiol. 2006 Dec 1;577(Pt 2):467-78. Epub 2006 Sep 28. Review.

19.

Amniotic fluid-derived stem cells as a cell source for bone tissue engineering.

Rodrigues MT, Lee SJ, Gomes ME, Reis RL, Atala A, Yoo JJ.

Tissue Eng Part A. 2012 Dec;18(23-24):2518-27. doi: 10.1089/ten.tea.2011.0672. Epub 2012 Aug 14.

PMID:
22891759
20.

Isolation and characterization of a Sca-1+/CD31- progenitor cell lineage derived from mouse heart tissue.

Wang H, Chen H, Feng B, Wang X, He X, Hu R, Yin M, Wang W, Fu W, Xu Z.

BMC Biotechnol. 2014 Aug 9;14:75. doi: 10.1186/1472-6750-14-75.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk